BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cross TJS, Calvaruso V, Foxton MR, Manousou P, Quaglia A, Grillo F, Dhillon AP, Nolan J, Chang TP, O’grady J, Heneghan MA, O’beirne JP, Burroughs AK, Harrison PM. A simple, noninvasive test for the diagnosis of liver fibrosis in patients with hepatitis C recurrence after liver transplantation: Noninvasive test for hepatitis C-related fibrosis post-LT. Journal of Viral Hepatitis 2010;17:640-9. [DOI: 10.1111/j.1365-2893.2009.01222.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Wang Q, Li H, Ding D, Peng M, Ren H, Hu P. Upgrade Combination Response Is Limited by Prolonged Nucelos(t)ide Analogue Therapy in HBeAg-positive Chronic Hepatitis B: A Real-life Study. J Clin Transl Hepatol 2018;6:11-7. [PMID: 29577027 DOI: 10.14218/JCTH.2017.00020] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Tanaka T, Therapondos G, Selzner N, Renner EL, Lilly LB. Serum aspartate aminotransferase levels and previous histopathological findings enable reduction of protocol liver biopsies after liver transplantation for hepatitis C. Can J Gastroenterol 2013;27:131-6. [PMID: 23516677 DOI: 10.1155/2013/904636] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
3 Zhang M, Zhang L, Li H, Chen Z, Luo A, Liu B, Chen M, Peng M, Ren H, Hu P. Circulating T follicular helper cells are associated with rapid virological response in chronic hepatitis C patients undergoing peginterferon therapy. Int Immunopharmacol 2016;34:235-43. [PMID: 26971227 DOI: 10.1016/j.intimp.2016.03.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
4 Cholongitas E, Tsochatzis E, Goulis J, Burroughs AK. Noninvasive tests for evaluation of fibrosis in HCV recurrence after liver transplantation: a systematic review. Transpl Int. 2010;23:861-870. [PMID: 20704691 DOI: 10.1111/j.1432-2277.2010.01142.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
5 Berenguer M, Charco R, Manuel Pascasio J, Ignacio Herrero J. Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation. Liver Int. 2012;32:712-731. [PMID: 22221843 DOI: 10.1111/j.1478-3231.2011.02731.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
6 Vasavada B. Prior Trans-arterial chemoembolization - A protective factor against rapid HCV recurrence post liver transplant in patients with HCV with HCC? - A Retrospective Cohort Study. Int J Surg 2016;30:132-5. [PMID: 27154618 DOI: 10.1016/j.ijsu.2016.04.050] [Reference Citation Analysis]
7 Pinato DJ, Karamanakos G, Ishizuka M, Smirne C, Pirisi M, Kubota K, Sharma R. The Kings Score refines prognostic prediction in hepatocellular carcinoma: a novel application. Liver Int 2015;35:2458-65. [PMID: 25845291 DOI: 10.1111/liv.12841] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
8 J.s. Cross T, Jothimani D, Heneghan MA, Harrison PM. Non-invasive assessment of fibrosis in liver grafts due to hepatitis C virus recurrence: Non-invasive assessment of HCV post OLT. Clinical Transplantation 2011;25:345-51. [DOI: 10.1111/j.1399-0012.2011.01396.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
9 Alqahtani SA, Larson AM. Adult liver transplantation in the USA: . Current Opinion in Gastroenterology 2011;27:240-7. [DOI: 10.1097/mog.0b013e3283457d5d] [Cited by in Crossref: 26] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
10 Joshi D, Pinzani M, Carey I, Agarwal K. Recurrent HCV after liver transplantation-mechanisms, assessment and therapy. Nat Rev Gastroenterol Hepatol. 2014;11:710-721. [PMID: 25023032 DOI: 10.1038/nrgastro.2014.114] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
11 Cano A, Mariño Z, Millet O, Martínez-Arranz I, Navasa M, Falcón-Pérez JM, Pérez-Cormenzana M, Caballería J, Embade N, Forns X, Bosch J, Castro A, Mato JM. A Metabolomics Signature Linked To Liver Fibrosis In The Serum Of Transplanted Hepatitis C Patients. Sci Rep 2017;7:10497. [PMID: 28874799 DOI: 10.1038/s41598-017-10807-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
12 Yoshino K, Taura K, Okuda Y, Ikeno Y, Uemoto Y, Nishio T, Yamamoto G, Tanabe K, Koyama Y, Seo S, Kaido T, Okajima H, Imai T, Tanaka S, Uemoto S. Efficiency of acoustic radiation force impulse imaging for the staging of graft fibrosis after liver transplantation. Hepatol Res 2019;49:394-403. [PMID: 30471140 DOI: 10.1111/hepr.13289] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Adebajo CO, Talwalkar JA, Poterucha JJ, Kim WR, Charlton MR. Ultrasound-based transient elastography for the detection of hepatic fibrosis in patients with recurrent hepatitis C virus after liver transplantation: a systematic review and meta-analysis. Liver Transpl. 2012;18:323-331. [PMID: 22140010 DOI: 10.1002/lt.22460] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 5.4] [Reference Citation Analysis]
14 Crespo G, Forns X, Navasa M. [Serum markers of liver fibrosis in patients with chronic hepatitis C infection. Prognostic value of noninvasive markers of fibrosis in liver transplantation]. Gastroenterol Hepatol 2012;35 Suppl 2:17-22. [PMID: 23298655 DOI: 10.1016/S0210-5705(12)70045-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 Shin N, Choi JA, Choi JM, Cho ES, Kim JH, Chung JJ, Yu JS. Sclerotic changes of cavernous hemangioma in the cirrhotic liver: long-term follow-up using dynamic contrast-enhanced computed tomography. Radiol Med 2020;125:1225-32. [PMID: 32415477 DOI: 10.1007/s11547-020-01221-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Akamatsu N, Sugawara Y. Liver transplantation and hepatitis C. Int J Hepatol 2012;2012:686135. [PMID: 22900194 DOI: 10.1155/2012/686135] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
17 Jiménez-luévano MÁ, Lerma-díaz JM, Hernández-flores G, Jiménez-partida MÁ, Bravo-cuellar A. Addition of pentoxifylline to pegylated interferon-alpha-2a and ribavirin improves sustained virological response to chronic hepatitis C virus: a randomized clinical trial. Annals of Hepatology 2013;12:248-55. [DOI: 10.1016/s1665-2681(19)31363-8] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
18 Alqahtani SA. Update in liver transplantation. Curr Opin Gastroenterol. 2012;28:230-238. [PMID: 22450898 DOI: 10.1097/mog.0b013e3283527f16] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
19 Howell J, Angus P, Gow P. Hepatitis C recurrence: the Achilles heel of liver transplantation. Transpl Infect Dis. 2014;16:1-16. [PMID: 24372756 DOI: 10.1111/tid.12173] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]